US pharma large Gilead’s partnership with home generic producers, aimed toward enhancing entry to inexpensive lenacapavir—a groundbreaking remedy for HIV prevention—could fall quick in addressing the wants of high-incidence growing
All posts tagged in Lenacapavir
2Articles
Dr Reddy’s Laboratories HYDERABAD: Dr Reddy’s Laboratories and Hetero are amongst half a dozen generic drug makers to have entered into non-exclusive, royalty-free voluntary licencing agreements with Gilead Sciences Eire
Advertisement
